Partner Content Partner Content Highly Potent APIs 2019 Conference: Interview with Bayer Pha... Latest Developments in HPAPI
Events Partner Content Limited Places Available for J+D Forecasting Training Zurich Limited places for J+D's Pharma Forecasting Training
Partner Content Partner Content J+D and the University of Bath School of Management Collabor... J+D recently provided forecasting training materials to the Strategy & Organisation Division of the University of Bath School of Management.
Partner Content Partner Content Shortlist for Best Pharma Partnership with NHS at HSJ Partne... HSJ Shortlist announcement
Events Partner Content The Pharma Forecasting Workshop - Fundamentals of Forecastin... J+D Interactive Pharma Forecasting Workshop
Partner Content Partner Content Antibiotic Class Emerges through Digestive Enzyme SMi Group Reports: The official agenda and highlights
News J&J scores EU approval for Tecvayli combo in second line Johnson & Johnson's multiple myeloma regimen is now approved as a second line treatment in both the US and the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
